These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8957964)

  • 1. Proinflammatory and anti-inflammatory cytokines in meningococcal disease.
    Riordan FA; Marzouk O; Thomson AP; Sills JA; Hart CA
    Arch Dis Child; 1996 Nov; 75(5):453-4. PubMed ID: 8957964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock.
    Derkx B; Marchant A; Goldman M; Bijlmer R; van Deventer S
    J Infect Dis; 1995 Jan; 171(1):229-32. PubMed ID: 7798670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock.
    Kornelisse RF; Hazelzet JA; Savelkoul HF; Hop WC; Suur MH; Borsboom AN; Risseeuw-Appel IM; van der Voort E; de Groot R
    J Infect Dis; 1996 May; 173(5):1148-56. PubMed ID: 8627066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections.
    van Deuren M; van der Ven-Jongekrijg J; Bartelink AK; van Dalen R; Sauerwein RW; van der Meer JW
    J Infect Dis; 1995 Aug; 172(2):433-9. PubMed ID: 7622886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease.
    Lehmann AK; Halstensen A; Sørnes S; Røkke O; Waage A
    Infect Immun; 1995 Jun; 63(6):2109-12. PubMed ID: 7768588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of correlation between soluble CD14 and IL-6 in meningococcal septic shock.
    Arranz E; Blanco-Quirós A; Solís P; Garrote JA
    Pediatr Allergy Immunol; 1997 Nov; 8(4):194-9. PubMed ID: 9553985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity.
    Gårdlund B; Sjölin J; Nilsson A; Roll M; Wickerts CJ; Wretlind B
    J Infect Dis; 1995 Jul; 172(1):296-301. PubMed ID: 7797935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does granulocyte colony-stimulating factor ameliorate the proinflammatory response in human meningococcal septic shock?
    Rojahn A; Brusletto B; Øvstebø R; Haug KB; Kierulf P; Brandtzaeg P
    Crit Care Med; 2008 Sep; 36(9):2583-9. PubMed ID: 18679115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory cytokine profile and mortality in febrile patients.
    van Dissel JT; van Langevelde P; Westendorp RG; Kwappenberg K; Frölich M
    Lancet; 1998 Mar; 351(9107):950-3. PubMed ID: 9734942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease.
    Sprong T; van der Ven-Jongekrijg J; Neeleman C; van der Meer JW; van Deuren M
    Crit Care Med; 2009 Oct; 37(10):2812-8. PubMed ID: 19707127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the interleukin-6/soluble interleukin-6 receptor axis in meningococcal septic shock.
    Pathan N; Williams EJ; Oragui EE; Stephens AC; Levin M
    Crit Care Med; 2005 Aug; 33(8):1839-44. PubMed ID: 16096463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
    Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
    Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock.
    Bjerre A; Brusletto B; Høiby EA; Kierulf P; Brandtzaeg P
    Crit Care Med; 2004 Feb; 32(2):433-8. PubMed ID: 14758160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis.
    Carrol ED; Thomson AP; Jones AP; Jeffers G; Hart CA
    Intensive Care Med; 2005 Oct; 31(10):1415-9. PubMed ID: 16132884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 12 levels during the initial phase of septic shock with purpura in children: relation to severity of disease.
    Hazelzet JA; Kornelisse RF; van der Pouw Kraan TC; Joosten KF; van der Voort E; van Mierlo G; Suur MH; Hop WC; de Groot R; Hack CE
    Cytokine; 1997 Sep; 9(9):711-6. PubMed ID: 9325021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin release and cytokine production in acute and chronic meningococcaemia.
    Prins JM; Lauw FN; Derkx BH; Speelman P; Kuijper EJ; Dankert J; van Deventer SJ
    Clin Exp Immunol; 1998 Nov; 114(2):215-9. PubMed ID: 9822279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease.
    De Kleijn ED; Joosten KF; Van Rijn B; Westerterp M; De Groot R; Hokken-Koelega AC; Hazelzet JA
    Pediatr Infect Dis J; 2002 Apr; 21(4):330-6. PubMed ID: 12075765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease.
    Halstensen A; Ceska M; Brandtzaeg P; Redl H; Naess A; Waage A
    J Infect Dis; 1993 Feb; 167(2):471-5. PubMed ID: 8421185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myositis in children with meningococcal disease: a role for tumour necrosis factor-alpha and interleukin-8?
    Carrol ED; Thomson AP; Mobbs KJ; Fraser WD; Sills JA; Hart CA
    J Infect; 2002 Jan; 44(1):17-21. PubMed ID: 11972413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
    Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
    J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.